Tower Research Capital (TRC)’s Vaccinex, Inc. Common Stock VCNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,883
| Closed | -$6.4K | – | 6129 |
|
|
2024
Q3 | $6.4K | Buy |
1,883
+559
| +42% | +$3.15K | ﹤0.01% | 4150 |
|
|
2024
Q2 | $8.59K | Buy |
1,324
+279
| +27% | +$1.69K | ﹤0.01% | 4331 |
|
|
2024
Q1 | $7.74K | Buy |
1,045
+570
| +120% | +$4.94K | ﹤0.01% | 4148 |
|
|
2023
Q4 | $4.43K | Buy |
475
+437
| +1,150% | +$5.17K | ﹤0.01% | 4957 |
|
|
2023
Q3 | $603 | Sell |
38
-112
| -75% | -$5.69K | ﹤0.01% | 5524 |
|
|
2023
Q2 | $11.2K | Buy |
150
+34
| +29% | +$2.83K | ﹤0.01% | 4006 |
|
|
2023
Q1 | $10K | Buy |
+116
| New | +$12.7K | ﹤0.01% | 4426 |
|
|
2022
Q1 | – | Sell |
-16
| Closed | -$3K | – | 6665 |
|
|
2021
Q4 | $3K | Buy |
16
+4
| +33% | +$1.44K | ﹤0.01% | 5517 |
|
|
2021
Q3 | $5K | Buy |
+12
| New | +$5.99K | ﹤0.01% | 4898 |
|
|
2021
Q2 | – | Sell |
-256
| Closed | -$161K | – | 5937 |
|
|
2021
Q1 | $161K | Buy |
256
+226
| +753% | +$145K | ﹤0.01% | 2186 |
|
|
2020
Q4 | $13K | Buy |
+30
| New | +$12.6K | ﹤0.01% | 4171 |
|
|
2020
Q3 | – | Sell |
-2
| Closed | -$2K | – | 5165 |
|
|
2020
Q2 | $2K | Buy |
+2
| New | +$1.56K | ﹤0.01% | 4548 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 4430 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 4383 |
|
|
2018
Q4 | – | Sell |
-8
| Closed | -$13K | – | 4473 |
|
|
2018
Q3 | $13K | Buy |
+8
| New | +$16.5K | ﹤0.01% | 2619 |
|
